Portal:CPTAC/FeaturedPathways
From WikiPathways
(Difference between revisions)
(draft) |
(Added additional pathways) |
||
Line 1: | Line 1: | ||
- | {| style="margin: 10px; background-color:# | + | {| style="margin: 10px; background-color:#eaf2ee" |
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | |width=100px; cell padding=50px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | ||
[http://dx.doi.org/10.1002/msb.20134892 Yang, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] | [http://dx.doi.org/10.1002/msb.20134892 Yang, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] | ||
|width=100px|{{#pwImage:Pathway:WP3972|250px||PDGFR-beta pathway}} | |width=100px|{{#pwImage:Pathway:WP3972|250px||PDGFR-beta pathway}} | ||
[http://dx.doi.org/10.1016/j.cell.2016.05.069 Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer] | [http://dx.doi.org/10.1016/j.cell.2016.05.069 Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2828|250px||Bladder Cancer}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP581|250px||EPO Receptor Signaling}} | ||
+ | |- | ||
+ | |width=100px|{{#pwImage:Pathway:WP673|250px||ErbB Signaling Pathway}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP585|250px||Interferon type I signaling pathways}} | ||
|} | |} |
Revision as of 22:23, 31 March 2017
Image does not exist |
Image does not exist Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |